METHOD FOR DETERMINING IF A PATIENT IS AT RISK OF HAVING OR DEVELOPING A COLORECTAL CANCER (CRC)
The present invention relates to a method for determining if a patient is at risk of having or developing a colorectal cancer (CRC). It further relates to a method for selecting a patient who will most likely benefit from a preventive treatment with an antibiotic, in particular Vancomycin and/or wit...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention relates to a method for determining if a patient is at risk of having or developing a colorectal cancer (CRC). It further relates to a method for selecting a patient who will most likely benefit from a preventive treatment with an antibiotic, in particular Vancomycin and/or with injections of recombinant human IL-22 and/or anti- human IL-17A antibody.
La présente invention concerne un procédé permettant de déterminer si un patient risque de présenter ou de développer un cancer colorectal. L'invention concerne en outre un procédé de sélection du patient qui sera le plus susceptible de bénéficier d'un traitement préventif impliquant un antibiotique, en particulier la vancomycine, et/ou des injections d'IL-22 humaine recombinée et/ou d'anticorps anti-IL-17 humaine recombinés. |
|---|